ZA874682B - Variants of glycosylated human alpa-antitrypsin and method for preparing them - Google Patents

Variants of glycosylated human alpa-antitrypsin and method for preparing them

Info

Publication number
ZA874682B
ZA874682B ZA874682A ZA874682A ZA874682B ZA 874682 B ZA874682 B ZA 874682B ZA 874682 A ZA874682 A ZA 874682A ZA 874682 A ZA874682 A ZA 874682A ZA 874682 B ZA874682 B ZA 874682B
Authority
ZA
South Africa
Prior art keywords
alpa
antitrypsin
variants
preparing
glycosylated human
Prior art date
Application number
ZA874682A
Inventor
Skern Tim
Jallat Sophie
Courtney Michael
Original Assignee
Transgene S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene S.A. filed Critical Transgene S.A.
Publication of ZA874682B publication Critical patent/ZA874682B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA874682A 1986-07-02 1987-06-29 Variants of glycosylated human alpa-antitrypsin and method for preparing them ZA874682B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8609608A FR2601033B1 (en) 1986-07-02 1986-07-02 VARIANTS OF GLYCOSYLATED HUMAN ALPHA-ANTITRYSPIN AND PROCESS FOR THE PREPARATION

Publications (1)

Publication Number Publication Date
ZA874682B true ZA874682B (en) 1988-01-06

Family

ID=9336987

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA874682A ZA874682B (en) 1986-07-02 1987-06-29 Variants of glycosylated human alpa-antitrypsin and method for preparing them

Country Status (8)

Country Link
EP (1) EP0254614A1 (en)
JP (1) JPS63198982A (en)
KR (1) KR880001814A (en)
AU (1) AU7496887A (en)
DK (1) DK329687A (en)
FR (1) FR2601033B1 (en)
PT (1) PT85229B (en)
ZA (1) ZA874682B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2599752B1 (en) * 1986-06-10 1989-11-03 Transgene Sa ALPHA1- ANTITRYPSIN VARIANTS USEFUL IN PARTICULAR AS KALLIKREIN INHIBITORS
ES2066033T3 (en) * 1989-05-13 1995-03-01 Bayer Ag PROTEINASE INHIBITORS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
WO2010123290A2 (en) * 2009-04-22 2010-10-28 (주)알테오젠 In vivo half life increased fusion protein or peptide maintained by sustained in vivo release, and method for increasing in vivo half-life using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0795954B2 (en) * 1982-11-30 1995-10-18 アメリカ合衆国 Method for producing recombinant poxvirus for expression of foreign gene
EP0114777B1 (en) * 1983-01-21 1990-08-01 Transgene S.A. Expression vehicles and their use in the preparation of a protein having human alpha-antitrypsin activity
ZA8410063B (en) * 1984-01-30 1985-10-30 Smith Kline Rit Expression of human alpha-1-antitrypsin in yeast
FR2563434B1 (en) 1984-04-25 1986-07-25 Transgene Sa Rabies vaccine and process for its preparation
JPH082307B2 (en) * 1984-05-22 1996-01-17 トランスジ−ン ソシエテ アノニム Method for producing factor IX
EP0164719B1 (en) * 1984-06-14 1992-05-06 Chiron Corporation Active site modified protease alpha-1-antitrypsin inhibitors and their production
EP0169114B1 (en) * 1984-06-19 1991-01-16 Transgene S.A. Human alpha-1-antitrypin derivatives and process for their preparation

Also Published As

Publication number Publication date
AU7496887A (en) 1988-01-07
FR2601033A1 (en) 1988-01-08
JPS63198982A (en) 1988-08-17
PT85229A (en) 1987-08-01
KR880001814A (en) 1988-04-27
PT85229B (en) 1990-03-30
DK329687A (en) 1988-01-03
DK329687D0 (en) 1987-06-26
EP0254614A1 (en) 1988-01-27
FR2601033B1 (en) 1990-01-19

Similar Documents

Publication Publication Date Title
PT85760A (en) Vaccine and method of preparation
GR871295B (en) Pastry and preparation method therefor
EP0233615A3 (en) Aqueous preparation and method of preparation thereof
BG46981A1 (en) Method for preparing of human leucocytaric alpha- 2- interferon
ZA874682B (en) Variants of glycosylated human alpa-antitrypsin and method for preparing them
CS186887A2 (en) Method of alkylsuphonyl-alkylchlorobenzenes preparation
GB2196002B (en) Preparation of polyfluoroaldehydes and polyfluoroacetals
GB2190373B (en) Method of preparing bromobenzotrifluoride
IL83539A (en) Method of preparation of anilinofumarate
CS821986A1 (en) Method of preparation of chestnut-extract
CS25886A1 (en) 2-substituted-5-arylfurans and method of their preparation
CS841188A1 (en) Method of trisdiethylaminosiliciumchloride preparation
BG42579A1 (en) Method for preparing of c below 6- alkenes and c below 6- epoxy- compounds
CS945586A1 (en) Aqua-l-asparagane-magnesium complex and method of its preparation
IE872543L (en) Vaccine and method of preparation
ZA877087B (en) Vaccine and method of preparation
CS52988A1 (en) Method of hydroxyethylmetacrylate and ethylenglycoldimetacrylate simultaneous preparation
CS947586A1 (en) Method of chlorofluoropropanes preparation
BG40573A1 (en) Method for simultaneous preparing of acetoxymethyllongipholene and isolongipholene
CS807687A1 (en) Alkylidenmalonaldehydes and method of their preparation
BG46371A1 (en) Polyethyethylenglycolfumarates and method for their preparation
BG42253A1 (en) Benzylthiocarbamides and method for their preparation
BG42582A1 (en) Reagent and method for preparing of amidophosphites
CS856488A1 (en) 3-allyl-6-nitro-2-benzothiazolinone and method of its preparation
CS120788A1 (en) 2-bromomethylphenylisocyanate and method of its preparation